Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice

Journal of Veterinary Science

Volumn 6, Issue 2, 2005, Pages 125-133

  Yang, Dong Kun ^a   Kweon, Chang Hee ^a   Kim, Byoung Han ^a   Lim, Seong In ^a   Kwon, Jun Hun ^a   Kim, Seong Hee ^a   Song, Jae Young ^a   Han, Hong Ryul ^b  

^a Ministry of Agriculture and Forestry Korea   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Baculovirus; Japanese encephalitis virus; JEV; Protective immunity

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; NONSTRUCTURAL PROTEIN 1; PREMEMBRANE AND ENVELOPE PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HELPER CELL; HEMAGGLUTINATION; IMMUNOGENICITY; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROVOCATION TEST; VIRUS ENVELOPE; VIRUS INFECTION; WESTERN BLOTTING;

ANIMALIA; JAPANESE ENCEPHALITIS VIRUS; SPODOPTERA FRUGIPERDA;

EID: 20444408017     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2005.6.2.125     Document Type: Article

References (32)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383, 787-793.
2. Burke DS, Monath TP. Fields Virology, 4th ed. pp. 991-1055, Lippincott, Philadelphia, 2001.
3. Chambers TJ, Tsai TF, Previkov Y, Monath TP. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 1997, 15, 1494-1502.
4. Chia SC, Leung PS, Liao CP, Huang JH, Lee ST. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Microb Pathog 2001, 31, 9-19.
5. Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL, Tao MH. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999, 73, 10137-10145.
6. Clarke DH, Casals K. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958, 7, 561-573.
7. Heinz FX, Stiasny K, Puschner-Auer G, Holzmann H, Allison SL, Mandl CW, Kunz C. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 1994, 198, 109-117.
8. Jacobs SC, Stephenson JR, Wilkinson GW. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol 1992, 66, 2086-2095.
9. Joo HS, Chu RM. Diseases of swine, 8 th ed. pp. 173-185, Iowa State University Press. Ames, 1999.
10. Konishi E, Fujii E, Mason PW. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol 2001, 75, 2204-2212.
11. Konishi E, Mason PW, Shope RE. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. J Med Virol 1996, 48, 76-79.
12. Konishi E, Pincus S, Paoletti E, Laegreid WW, Shope RE, Mason PW. A highly attenuated host range-restricted vaccinia virus strain. NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 1992, 190, 454-458.
13. Kwon HJ, Kang BJ, Lim YM, Lee CK. Studies on Japanese encephalitis live vaccine. IV. Immunization of pigs with Anyang strain attenuated virus. Res Rep Off Rural Dev 1978, 19, 7-12.
14. Lin YL, Chen LK, Liao CL, Yen CT, Ma SH, Chen JL, Huang YL, Chen SS, Chiang HY. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 1998, 72, 191-200.
15. Lorenz IC, Allison SL, Heinz FX, Helenius A. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 2002, 76, 5480-5491.
16. Mackenzie JS, Chua KB, Daniels PW, Eaton BT, Field HE, Hall RA, Halpin K et al. Emerging viral diseases of South East Asia and the Western Pacific: A brief review. Emerg Infect Dis 2001, 7, 497-504.
17. Marx F, Gritsun TS, Grubeck-Loebenstein B, Gould EA. Diagnostic immunoassays for tick-born encephalitis virus based on recombinant baculovirus protein expression. J Virol Methods 2001, 91, 75-84.
18. Mason P, Pincus S, Fournier MJ, Mason TL, Shope RE, Paoletti E. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 1991, 180, 294-305.
19. Mason PW, Zugel MU, Semproni AR, Fournier MJ, Mason TL. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J Gen Virol 1990, 71, 2107-2114.
20. Matsuura Y, Miyamoto M, Sato T, Morita C, Yasui K. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology 1989, 173, 674-682.
21. McMinn PC. The molecular basis of virulence of the encephalogenic flaviviruses. J Gen Virol 1997, 78, 2711-2722.
22. Nam JH, Chae SL, Won SY, Kim EJ, Yoon KS, Kim BI, Jeong YS, Cho HW. Genetic Heterogeneity of Japanese encephalitis virus assessed via analysis of the full-length genome sequence of Korean isolate. Am J Trop Med Hyg 2001, 65, 388-392.
23. Park JH. Studies on DNA-based vaccines of Japanese encephalitis. Ph.D thesis, Chungnam National University, Korea. 2002, 58-134.
24. Possee RD. Baculovirus as expression vectors. Curr Opin Biotechnol 1997, 8, 569-572.
25. Schlesinger JJ, Brandriss MW, Walsy EE. Protein against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 1985, 135, 2805-2809.
26. Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Cell surface expression of yellow fever virus non-structural glycoprotein NS1; consequences of interaction with antibody. J Gen Virol 1990, 71, 593-599.
27. Shimizu T, Kawakami Y, Fukuhara S, Matumoto M. Experimental stillbirth in pregnant swine infected with Japanese encephalitis virus. Japan J Exp Med 1954, 24, 363-375.
28. Sugrue RJ, Fu J, Howe J, Chan YC. Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles. J Gen Virol 1997, 78, 1861-1866.
29. Ting SH, See E, Tan HC, Lee MA, Ooi EE. Development of a simplified assay for the detection of neutralization antibodies to Japanese encephalitis virus. J Virol Methods 2001, 93, 43-47.
30. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO CV1 meeting Bangkok, Thailand, 13-15 October 1998. Vaccine 2000, 8, 1-25.
31. Wengler G, Wengler G, Nowak T, Wahn K. Analysis of the influence of proteolytic cleavage on the structural organization of the surface of the West Nile flavivirus leads to the isolation of a protease-resistant E protein oligomer from the viral surface. Virology 1987, 160, 210-219.
32. Yang DK, Kim BH, Kweon CH, Kwon JH, Lim SI, Han HR. Biophysical characterization of Japanese encephalitis virus (KV1899) isolated from pigs in Korea. J Vet Sci 2004, 5, 125-130.